Table 1. Baseline characteristics of hybrid coronary revascularization and PCI patients: New York, 2010-2016.
| Prevalence in HCR patients
(n = 335) |
Prevalence in PCI patients
(n = 27,557) |
P-value for univariate
analysis |
|
| Data are presented as n (%). BMI: body mass index; LAD: left anterior descending; PCI: percutaneous coronary intervention. | |||
| Demographic | |||
| Patient age, yrs | 0.28 | ||
| 18−44 | 8 (2.39%) | 933 (3.39%) | |
| 45−54 | 56 (16.72%) | 4083 (14.82%) | |
| 55−64 | 97 (28.96%) | 8028 (29.13%) | |
| 65−74 | 108 (32.24%) | 7987 (28.98%) | |
| 75−84 | 55 (16.42%) | 5066 (18.38%) | |
| ≥ 85 | 11 (3.28%) | 1460 (5.30%) | |
| Sex | 0.0042 | ||
| Male | 263 (78.51%) | 19,676 (71.40%) | |
| Female | 72 (21.49%) | 7881 (28.60%) | |
| BMI | 0.030 | ||
| < 18.5 kg/m 2 | 4 (1.19%) | 219 (0.79%) | |
| ≥ 18.5 and < 25 kg/m 2 | 89 (26.57%) | 5755 (20.88%) | |
| ≥ 25 and < 30 kg/m 2 | 127 (37.91%) | 10,657 (38.67%) | |
| ≥ 30 and < 35 kg/m 2 | 81 (24.18%) | 6702 (24.32%) | |
| ≥ 35 and < 40 kg/m 2 | 25 (7.46%) | 2736 (9.93%) | |
| ≥ 40 kg/m2 | 9 (2.69%) | 1488 (5.40%) | |
| Ventricular function | |||
| Ejection fraction | 0.068 | ||
| Ejection fraction 50% or greater | 250 (74.63%) | 19,807 (71.88%) | |
| Ejection fraction 40%−49% | 55 (16.42%) | 4319 (15.67%) | |
| Ejection fraction 30%−39% | 25 (7.46%) | 2048 (7.43%) | |
| Ejection fraction 20%−29% | 4 (1.19%) | 1142 (4.14%) | |
| Ejection fraction less than 20% | 1 (0.30%) | 241 (0.87%) | |
| Pre−procedural MI | 0.0037 | ||
| STEMI in 24 h | 32 (9.55%) | 3459 (12.55%) | |
| NSTEMI in 24 h | 8 (2.39%) | 1561 (5.66%) | |
| MI with or without ST elevation 1−20 days | 57 (17.01%) | 5323 (19.32%) | |
| No MI within 20 days | 238 (71.04%) | 17,214 (62.47%) | |
| Patient history | |||
| Previous PCI procedure | 57 (17.01%) | 4708 (17.08%) | 0.97 |
| Comorbidities | |||
| Congestive heart failure | 0.042 | ||
| Current | 26 (7.76%) | 1954 (7.09%) | |
| Past | 16 (4.78%) | 721 (2.62%) | |
| None | 293 (87.46%) | 24,882 (90.29%) | |
| Chronic lung disease | 16 (4.78%) | 1576 (5.72%) | 0.46 |
| Cerebrovascular disease | 34 (10.15%) | 2377 (8.63%) | 0.32 |
| Peripheral vascular disease | 28 (8.36%) | 2014 (7.31%) | 0.46 |
| Diabetes requiring medication | 119 (35.52%) | 9383 (34.05%) | 0.57 |
| Renal Failure | 0.71 | ||
| Creatinine ≤ 1.2 mg/dL | 249 (74.33%) | 19,890 (72.18%) | |
| Creatinine > 1.2 and ≤ 1.5 mg/dL | 63 (18.81%) | 5357 (19.44%) | |
| Creatinine > 1.5 and ≤ 2.0 mg/dL | 11 (3.28%) | 1222 (4.43%) | |
| Creatinine > 2.0 mg/dL or Require renal dialysis | 12 (3.58%) | 1088 (3.95%) | |
| Vessels | |||
| 3-vessel disease | 174 (51.94%) | 9694 (35.18%) | < 0.0001 |
| Proximal LAD disease | 232 (69.25%) | 11,710 (42.49%) | < 0.0001 |
| LMT disease | 45 (13.43%) | 665 (2.41%) | < 0.0001 |